nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—NPY1R—Endothelin Pathways—ADCY10—nephrolithiasis	0.047	0.218	CbGpPWpGaD
Venlafaxine—Anxiety disorder—Hydrochlorothiazide—nephrolithiasis	0.0412	0.0614	CcSEcCtD
Venlafaxine—Tramadol—CHRM3—nephrolithiasis	0.021	0.557	CrCbGaD
Venlafaxine—Cyclopentolate—CHRM3—nephrolithiasis	0.0167	0.443	CrCbGaD
Venlafaxine—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0199	CcSEcCtD
Venlafaxine—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0121	0.018	CcSEcCtD
Venlafaxine—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0121	0.018	CcSEcCtD
Venlafaxine—CYP2C19—urine—nephrolithiasis	0.012	0.161	CbGeAlD
Venlafaxine—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0169	CcSEcCtD
Venlafaxine—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0169	CcSEcCtD
Venlafaxine—CYP2C9—urine—nephrolithiasis	0.00929	0.125	CbGeAlD
Venlafaxine—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0138	CcSEcCtD
Venlafaxine—NPY1R—renal system—nephrolithiasis	0.00918	0.123	CbGeAlD
Venlafaxine—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00885	0.0132	CcSEcCtD
Venlafaxine—NPY1R—cortex of kidney—nephrolithiasis	0.00864	0.116	CbGeAlD
Venlafaxine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00833	0.0124	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00831	0.0385	CbGpPWpGaD
Venlafaxine—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00787	0.0117	CcSEcCtD
Venlafaxine—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0107	CcSEcCtD
Venlafaxine—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00711	0.0106	CcSEcCtD
Venlafaxine—CYP3A4—urine—nephrolithiasis	0.00708	0.0949	CbGeAlD
Venlafaxine—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00706	0.0105	CcSEcCtD
Venlafaxine—CYP2D6—urine—nephrolithiasis	0.00697	0.0934	CbGeAlD
Venlafaxine—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00687	0.0102	CcSEcCtD
Venlafaxine—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00687	0.0102	CcSEcCtD
Venlafaxine—Gout—Hydrochlorothiazide—nephrolithiasis	0.00683	0.0102	CcSEcCtD
Venlafaxine—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00674	0.01	CcSEcCtD
Venlafaxine—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00991	CcSEcCtD
Venlafaxine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00966	CcSEcCtD
Venlafaxine—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00966	CcSEcCtD
Venlafaxine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00638	0.00949	CcSEcCtD
Venlafaxine—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00932	CcSEcCtD
Venlafaxine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00602	0.00896	CcSEcCtD
Venlafaxine—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.00599	0.0278	CbGpPWpGaD
Venlafaxine—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00891	CcSEcCtD
Venlafaxine—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00867	CcSEcCtD
Venlafaxine—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00858	CcSEcCtD
Venlafaxine—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00858	CcSEcCtD
Venlafaxine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00796	CcSEcCtD
Venlafaxine—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00792	CcSEcCtD
Venlafaxine—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00785	CcSEcCtD
Venlafaxine—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00777	CcSEcCtD
Venlafaxine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00517	0.0077	CcSEcCtD
Venlafaxine—Injury—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00749	CcSEcCtD
Venlafaxine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00499	0.00743	CcSEcCtD
Venlafaxine—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00736	CcSEcCtD
Venlafaxine—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00733	CcSEcCtD
Venlafaxine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0073	CcSEcCtD
Venlafaxine—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0073	CcSEcCtD
Venlafaxine—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00488	0.00727	CcSEcCtD
Venlafaxine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00488	0.00727	CcSEcCtD
Venlafaxine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00486	0.00724	CcSEcCtD
Venlafaxine—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00486	0.00724	CcSEcCtD
Venlafaxine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00715	CcSEcCtD
Venlafaxine—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00709	CcSEcCtD
Venlafaxine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00692	CcSEcCtD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00463	0.0215	CbGpPWpGaD
Venlafaxine—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00689	CcSEcCtD
Venlafaxine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00683	CcSEcCtD
Venlafaxine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00456	0.00678	CcSEcCtD
Venlafaxine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00456	0.00678	CcSEcCtD
Venlafaxine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00665	CcSEcCtD
Venlafaxine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00653	CcSEcCtD
Venlafaxine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00648	CcSEcCtD
Venlafaxine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00645	CcSEcCtD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00431	0.0199	CbGpPWpGaD
Venlafaxine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00636	CcSEcCtD
Venlafaxine—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00631	CcSEcCtD
Venlafaxine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00629	CcSEcCtD
Venlafaxine—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00627	CcSEcCtD
Venlafaxine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00417	0.0062	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00417	0.0062	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00417	0.0062	CcSEcCtD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0041	0.019	CbGpPWpGaD
Venlafaxine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0041	0.0061	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00608	CcSEcCtD
Venlafaxine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00608	CcSEcCtD
Venlafaxine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00599	CcSEcCtD
Venlafaxine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.004	0.00595	CcSEcCtD
Venlafaxine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.004	0.00595	CcSEcCtD
Venlafaxine—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00584	CcSEcCtD
Venlafaxine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0039	0.0058	CcSEcCtD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00381	0.0177	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00376	0.0174	CbGpPWpGaD
Venlafaxine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00557	CcSEcCtD
Venlafaxine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00557	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00553	CcSEcCtD
Venlafaxine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0037	0.0055	CcSEcCtD
Venlafaxine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00548	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00365	0.00543	CcSEcCtD
Venlafaxine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00542	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00361	0.0167	CbGpPWpGaD
Venlafaxine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00537	CcSEcCtD
Venlafaxine—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00534	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00526	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00523	CcSEcCtD
Venlafaxine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00522	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0052	CcSEcCtD
Venlafaxine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0052	CcSEcCtD
Venlafaxine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00517	CcSEcCtD
Venlafaxine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00516	CcSEcCtD
Venlafaxine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00509	CcSEcCtD
Venlafaxine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00506	CcSEcCtD
Venlafaxine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00501	CcSEcCtD
Venlafaxine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00498	CcSEcCtD
Venlafaxine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00495	CcSEcCtD
Venlafaxine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00485	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00323	0.0149	CbGpPWpGaD
Venlafaxine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00478	CcSEcCtD
Venlafaxine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00477	CcSEcCtD
Venlafaxine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00474	CcSEcCtD
Venlafaxine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00473	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0031	0.0144	CbGpPWpGaD
Venlafaxine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00459	CcSEcCtD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00304	0.0141	CbGpPWpGaD
Venlafaxine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00451	CcSEcCtD
Venlafaxine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00444	CcSEcCtD
Venlafaxine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00442	CcSEcCtD
Venlafaxine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00426	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—RGS14—nephrolithiasis	0.00284	0.0132	CbGpPWpGaD
Venlafaxine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00421	CcSEcCtD
Venlafaxine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00415	CcSEcCtD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00278	0.0129	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00278	0.0129	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00275	0.0127	CbGpPWpGaD
Venlafaxine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00409	CcSEcCtD
Venlafaxine—ABCG2—nephron tubule—nephrolithiasis	0.00274	0.0367	CbGeAlD
Venlafaxine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00407	CcSEcCtD
Venlafaxine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00406	CcSEcCtD
Venlafaxine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00403	CcSEcCtD
Venlafaxine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00401	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00269	0.0125	CbGpPWpGaD
Venlafaxine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00399	CcSEcCtD
Venlafaxine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00391	CcSEcCtD
Venlafaxine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00389	CcSEcCtD
Venlafaxine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00385	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—RGS14—nephrolithiasis	0.00258	0.012	CbGpPWpGaD
Venlafaxine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00383	CcSEcCtD
Venlafaxine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00381	CcSEcCtD
Venlafaxine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00379	CcSEcCtD
Venlafaxine—CYP2B6—nephron tubule—nephrolithiasis	0.00253	0.0338	CbGeAlD
Venlafaxine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00374	CcSEcCtD
Venlafaxine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00373	CcSEcCtD
Venlafaxine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00372	CcSEcCtD
Venlafaxine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00371	CcSEcCtD
Venlafaxine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00367	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00246	0.0114	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00246	0.0114	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CHRM3—nephrolithiasis	0.00246	0.0114	CbGpPWpGaD
Venlafaxine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00365	CcSEcCtD
Venlafaxine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00362	CcSEcCtD
Venlafaxine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00353	CcSEcCtD
Venlafaxine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00353	CcSEcCtD
Venlafaxine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00353	CcSEcCtD
Venlafaxine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00352	CcSEcCtD
Venlafaxine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00349	CcSEcCtD
Venlafaxine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00345	CcSEcCtD
Venlafaxine—CYP2B6—renal system—nephrolithiasis	0.0023	0.0308	CbGeAlD
Venlafaxine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00341	CcSEcCtD
Venlafaxine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00339	CcSEcCtD
Venlafaxine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00339	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—PTH—nephrolithiasis	0.00225	0.0104	CbGpPWpGaD
Venlafaxine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00224	0.00333	CcSEcCtD
Venlafaxine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00332	CcSEcCtD
Venlafaxine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00222	0.0033	CcSEcCtD
Venlafaxine—CYP2B6—kidney—nephrolithiasis	0.00222	0.0297	CbGeAlD
Venlafaxine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00327	CcSEcCtD
Venlafaxine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00323	CcSEcCtD
Venlafaxine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00213	0.00316	CcSEcCtD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0021	0.00975	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0021	0.00975	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00308	CcSEcCtD
Venlafaxine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00306	CcSEcCtD
Venlafaxine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00304	CcSEcCtD
Venlafaxine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00302	CcSEcCtD
Venlafaxine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00301	CcSEcCtD
Venlafaxine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.002	0.00298	CcSEcCtD
Venlafaxine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00294	CcSEcCtD
Venlafaxine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00292	CcSEcCtD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00196	0.00906	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00196	0.00906	CbGpPWpGaD
Venlafaxine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00195	0.0029	CcSEcCtD
Venlafaxine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00195	0.0029	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—DGKH—nephrolithiasis	0.00192	0.00889	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00279	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00186	0.00864	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00186	0.00864	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00277	CcSEcCtD
Venlafaxine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00269	CcSEcCtD
Venlafaxine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00268	CcSEcCtD
Venlafaxine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00268	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—ADCY10—nephrolithiasis	0.00179	0.00831	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00174	0.00808	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—DGKH—nephrolithiasis	0.00174	0.00808	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00173	0.00803	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00173	0.00803	CbGpPWpGaD
Venlafaxine—CYP3A4—renal system—nephrolithiasis	0.00173	0.0232	CbGeAlD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00173	0.00802	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00173	0.00802	CbGpPWpGaD
Venlafaxine—CYP2D6—renal system—nephrolithiasis	0.00171	0.0229	CbGeAlD
Venlafaxine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00249	CcSEcCtD
Venlafaxine—CYP3A4—kidney—nephrolithiasis	0.00168	0.0225	CbGeAlD
Venlafaxine—CYP2D6—kidney—nephrolithiasis	0.00165	0.0221	CbGeAlD
Venlafaxine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00243	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.00163	0.00753	CbGpPWpGaD
Venlafaxine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0024	CcSEcCtD
Venlafaxine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00232	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00155	0.00716	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00154	0.00715	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00153	0.0071	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00153	0.0071	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RGS14—nephrolithiasis	0.00152	0.00706	CbGpPWpGaD
Venlafaxine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00224	CcSEcCtD
Venlafaxine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00215	CcSEcCtD
Venlafaxine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00213	CcSEcCtD
Venlafaxine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00213	CcSEcCtD
Venlafaxine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00212	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00141	0.00654	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00141	0.00654	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00141	0.00653	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00141	0.00653	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00139	0.00643	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00137	0.00633	CbGpPWpGaD
Venlafaxine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00201	CcSEcCtD
Venlafaxine—ABCB1—nephron tubule—nephrolithiasis	0.00135	0.0181	CbGeAlD
Venlafaxine—NPY1R—GPCR downstream signaling—PTH—nephrolithiasis	0.00127	0.00588	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CHRM3—nephrolithiasis	0.00126	0.00584	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00126	0.00582	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00125	0.00579	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00125	0.00579	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00123	0.00569	CbGpPWpGaD
Venlafaxine—ABCB1—renal system—nephrolithiasis	0.00123	0.0164	CbGeAlD
Venlafaxine—ABCB1—kidney—nephrolithiasis	0.00119	0.0159	CbGeAlD
Venlafaxine—ABCB1—cortex of kidney—nephrolithiasis	0.00116	0.0155	CbGeAlD
Venlafaxine—NPY1R—Signaling by GPCR—PTH—nephrolithiasis	0.00115	0.00534	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00115	0.00532	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00115	0.00532	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00113	0.00523	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00112	0.00519	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00107	0.00495	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00107	0.00495	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00103	0.00477	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—DGKH—nephrolithiasis	0.00103	0.00477	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000994	0.00461	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000994	0.00461	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000948	0.00439	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000948	0.00439	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000886	0.00411	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000886	0.00411	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000881	0.00408	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000881	0.00408	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000871	0.00404	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000871	0.00404	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00081	0.00375	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00081	0.00375	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000785	0.00364	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000785	0.00364	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000762	0.00353	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000762	0.00353	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CHRM3—nephrolithiasis	0.000745	0.00345	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000739	0.00342	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000722	0.00334	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000722	0.00334	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000709	0.00328	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTH—nephrolithiasis	0.000681	0.00315	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00068	0.00315	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000628	0.00291	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000621	0.00288	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000621	0.00288	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000577	0.00267	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000501	0.00232	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000471	0.00218	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000471	0.00218	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000446	0.00207	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000438	0.00203	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000438	0.00203	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00039	0.00181	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00039	0.00181	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—APRT—nephrolithiasis	0.000379	0.00176	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000379	0.00176	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000367	0.0017	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SPP1—nephrolithiasis	0.000342	0.00158	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000327	0.00151	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000312	0.00145	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000278	0.00129	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000278	0.00129	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000277	0.00128	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000271	0.00125	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AQP1—nephrolithiasis	0.00027	0.00125	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000255	0.00118	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000253	0.00117	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000247	0.00114	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000244	0.00113	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000241	0.00112	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000227	0.00105	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000225	0.00104	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—APRT—nephrolithiasis	0.00021	0.000973	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.00021	0.000973	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000205	0.00095	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000205	0.00095	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000198	0.000918	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000193	0.000895	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000193	0.000895	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000192	0.000887	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000192	0.000887	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000179	0.00083	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000167	0.000772	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.00015	0.000694	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000149	0.000688	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000146	0.000677	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000138	0.000638	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000137	0.000632	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000135	0.000627	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000132	0.000612	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000126	0.000585	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000126	0.000585	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000125	0.000577	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000123	0.000572	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AQP1—nephrolithiasis	9e-05	0.000417	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	8.14e-05	0.000377	CbGpPWpGaD
